Cargando…

Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study

OBJECTIVE: To estimate the effect of tocilizumab or glucocorticoids in preventing death and intubation in patients hospitalized with SARS-CoV-2 pneumonia. METHODS: This was a retrospective cohort study enrolling all consecutive patients hospitalized at Reggio Emilia AUSL between February the 11(th)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dolci, Giovanni, Cassone, Giulia, Besutti, Giulia, Corsini, Romina, Sampaolesi, Fabio, Iotti, Valentina, Galli, Elena, Palermo, Adalgisa, Fontana, Matteo, Mancuso, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687752/ https://www.ncbi.nlm.nih.gov/pubmed/34963560 http://dx.doi.org/10.1016/j.bjid.2021.101702

Ejemplares similares

Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis
por: Cassone, Giulia, et al.
Publicado: (2022)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Abdominal Visceral Infarction in 3 Patients with COVID-19
por: Besutti, Giulia, et al.
Publicado: (2020)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients
por: Besutti, Giulia, et al.
Publicado: (2021)

Use of tocilizumab in COVID-19 pneumonia hospitalized patients. Cohort study
por: Anci, Cynthia, et al.
Publicado: (2023)

Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
por: Mori, Shunsuke, et al.
Publicado: (2014)

Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy
por: Besutti, Giulia, et al.
Publicado: (2020)

The role of PET/CT in disease activity assessment in patients with large vessel vasculitis
por: Galli, Elena, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Glucocorticoides solos versus tocilizumab solo o glucocorticoides más tocilizumab en pacientes con neumonía grave por SARS-CoV-2 e inflamación moderada
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
por: Mussini, Cristina, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation
por: Potere, Nicola, et al.
Publicado: (2020)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

Tocilizumab and liver injury in patients with COVID-19
por: Serviddio, Gaetano, et al.
Publicado: (2020)

Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional study
por: Besutti, Giulia, et al.
Publicado: (2023)

The association between clinical laboratory data and chest CT findings explains disease severity in a large Italian cohort of COVID-19 patients
por: Canovi, Simone, et al.
Publicado: (2021)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
por: Salama, Carlos, et al.
Publicado: (2020)

Tocilizumab: Secondary organising pneumonia: case report
Publicado: (2022)

Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
por: Perrone, Francesco, et al.
Publicado: (2020)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

Successful treatment of granulomatosis with polyangiitis using tocilizumab combined with glucocorticoids: A case report
por: Tang, Peng-Fang, et al.
Publicado: (2023)

TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol
por: Piccirillo, Maria Carmela, et al.
Publicado: (2020)

Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients
por: Besutti, Giulia, et al.
Publicado: (2022)

Modifications of Chest CT Body Composition Parameters at Three and Six Months after Severe COVID-19 Pneumonia: A Retrospective Cohort Study
por: Besutti, Giulia, et al.
Publicado: (2022)

Editorial: Morphological and functional imaging: a combined approach
por: Albano, Domenico, et al.
Publicado: (2023)

Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
por: Iotti, Valentina, et al.
Publicado: (2021)

Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
por: Perrone, Francesco, et al.
Publicado: (2021)

Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
por: Zhang, Shengyu, et al.
Publicado: (2020)

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
por: Agirbasli, Mehmet, et al.
Publicado: (2021)

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
por: Antinori, Spinello, et al.
Publicado: (2020)

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
por: Morena, Valentina, et al.
Publicado: (2020)

An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy
por: Sakashita, Kentaro, et al.
Publicado: (2016)

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rbdfgm7ohdsv170bc9tbov57jm